Cargando…

Effect of human milk as a treatment for dry eye syndrome in a mouse model

PURPOSE: Dry eye syndrome (DES) affects millions of people worldwide. Homeopathic remedies to treat a wide variety of ocular diseases have previously been documented in the literature, but little systematic work has been performed to validate the remedies’ efficacy using accepted laboratory models o...

Descripción completa

Detalles Bibliográficos
Autores principales: Diego, Jose L., Bidikov, Luke, Pedler, Michelle G., Kennedy, Jeffrey B., Quiroz-Mercado, Hugo, Gregory, Darren G., Petrash, J. Mark, McCourt, Emily A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017541/
https://www.ncbi.nlm.nih.gov/pubmed/27667918
_version_ 1782452766155735040
author Diego, Jose L.
Bidikov, Luke
Pedler, Michelle G.
Kennedy, Jeffrey B.
Quiroz-Mercado, Hugo
Gregory, Darren G.
Petrash, J. Mark
McCourt, Emily A.
author_facet Diego, Jose L.
Bidikov, Luke
Pedler, Michelle G.
Kennedy, Jeffrey B.
Quiroz-Mercado, Hugo
Gregory, Darren G.
Petrash, J. Mark
McCourt, Emily A.
author_sort Diego, Jose L.
collection PubMed
description PURPOSE: Dry eye syndrome (DES) affects millions of people worldwide. Homeopathic remedies to treat a wide variety of ocular diseases have previously been documented in the literature, but little systematic work has been performed to validate the remedies’ efficacy using accepted laboratory models of disease. The purpose of this study was to evaluate the efficacy of human milk and nopal cactus (prickly pear), two widely used homeopathic remedies, as agents to reduce pathological markers of DES. METHODS: The previously described benzalkonium chloride (BAK) dry eye mouse model was used to study the efficacy of human milk and nopal cactus (prickly pear). BAK (0.2%) was applied to the mouse ocular surface twice daily to induce dry eye pathology. Fluorescein staining was used to verify that the animals had characteristic signs of DES. After induction of DES, the animals were treated with human milk (whole and fat-reduced), nopal, nopal extract derivatives, or cyclosporine four times daily for 7 days. Punctate staining and preservation of corneal epithelial thickness, measured histologically at the end of treatment, were used as indices of therapeutic efficacy. RESULTS: Treatment with BAK reduced the mean corneal epithelial thickness from 36.77±0.64 μm in the control mice to 21.29±3.2 μm. Reduction in corneal epithelial thickness was largely prevented by administration of whole milk (33.2±2.5 μm) or fat-reduced milk (36.1±1.58 μm), outcomes that were similar to treatment with cyclosporine (38.52±2.47 μm), a standard in current dry eye therapy. In contrast, crude or filtered nopal extracts were ineffective at preventing BAK-induced loss of corneal epithelial thickness (24.76±1.78 μm and 27.99±2.75 μm, respectively), as were solvents used in the extraction of nopal materials (26.53±1.46 μm for ethyl acetate, 21.59±5.87 μm for methanol). Epithelial damage, as reflected in the punctate scores, decreased over 4 days of treatment with whole and fat-reduced milk but continued to increase in eyes treated with nopal-derived materials. CONCLUSIONS: Whole and fat-reduced human milk showed promising effects in the prevention of BAK-induced loss of corneal epithelial thickness and epithelial damage in this mouse model. Further studies are required to determine whether human milk may be safely used to treat dry eye in patients.
format Online
Article
Text
id pubmed-5017541
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Molecular Vision
record_format MEDLINE/PubMed
spelling pubmed-50175412016-09-23 Effect of human milk as a treatment for dry eye syndrome in a mouse model Diego, Jose L. Bidikov, Luke Pedler, Michelle G. Kennedy, Jeffrey B. Quiroz-Mercado, Hugo Gregory, Darren G. Petrash, J. Mark McCourt, Emily A. Mol Vis Research Article PURPOSE: Dry eye syndrome (DES) affects millions of people worldwide. Homeopathic remedies to treat a wide variety of ocular diseases have previously been documented in the literature, but little systematic work has been performed to validate the remedies’ efficacy using accepted laboratory models of disease. The purpose of this study was to evaluate the efficacy of human milk and nopal cactus (prickly pear), two widely used homeopathic remedies, as agents to reduce pathological markers of DES. METHODS: The previously described benzalkonium chloride (BAK) dry eye mouse model was used to study the efficacy of human milk and nopal cactus (prickly pear). BAK (0.2%) was applied to the mouse ocular surface twice daily to induce dry eye pathology. Fluorescein staining was used to verify that the animals had characteristic signs of DES. After induction of DES, the animals were treated with human milk (whole and fat-reduced), nopal, nopal extract derivatives, or cyclosporine four times daily for 7 days. Punctate staining and preservation of corneal epithelial thickness, measured histologically at the end of treatment, were used as indices of therapeutic efficacy. RESULTS: Treatment with BAK reduced the mean corneal epithelial thickness from 36.77±0.64 μm in the control mice to 21.29±3.2 μm. Reduction in corneal epithelial thickness was largely prevented by administration of whole milk (33.2±2.5 μm) or fat-reduced milk (36.1±1.58 μm), outcomes that were similar to treatment with cyclosporine (38.52±2.47 μm), a standard in current dry eye therapy. In contrast, crude or filtered nopal extracts were ineffective at preventing BAK-induced loss of corneal epithelial thickness (24.76±1.78 μm and 27.99±2.75 μm, respectively), as were solvents used in the extraction of nopal materials (26.53±1.46 μm for ethyl acetate, 21.59±5.87 μm for methanol). Epithelial damage, as reflected in the punctate scores, decreased over 4 days of treatment with whole and fat-reduced milk but continued to increase in eyes treated with nopal-derived materials. CONCLUSIONS: Whole and fat-reduced human milk showed promising effects in the prevention of BAK-induced loss of corneal epithelial thickness and epithelial damage in this mouse model. Further studies are required to determine whether human milk may be safely used to treat dry eye in patients. Molecular Vision 2016-09-09 /pmc/articles/PMC5017541/ /pubmed/27667918 Text en Copyright © 2016 Molecular Vision. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited, used for non-commercial purposes, and is not altered or transformed.
spellingShingle Research Article
Diego, Jose L.
Bidikov, Luke
Pedler, Michelle G.
Kennedy, Jeffrey B.
Quiroz-Mercado, Hugo
Gregory, Darren G.
Petrash, J. Mark
McCourt, Emily A.
Effect of human milk as a treatment for dry eye syndrome in a mouse model
title Effect of human milk as a treatment for dry eye syndrome in a mouse model
title_full Effect of human milk as a treatment for dry eye syndrome in a mouse model
title_fullStr Effect of human milk as a treatment for dry eye syndrome in a mouse model
title_full_unstemmed Effect of human milk as a treatment for dry eye syndrome in a mouse model
title_short Effect of human milk as a treatment for dry eye syndrome in a mouse model
title_sort effect of human milk as a treatment for dry eye syndrome in a mouse model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017541/
https://www.ncbi.nlm.nih.gov/pubmed/27667918
work_keys_str_mv AT diegojosel effectofhumanmilkasatreatmentfordryeyesyndromeinamousemodel
AT bidikovluke effectofhumanmilkasatreatmentfordryeyesyndromeinamousemodel
AT pedlermichelleg effectofhumanmilkasatreatmentfordryeyesyndromeinamousemodel
AT kennedyjeffreyb effectofhumanmilkasatreatmentfordryeyesyndromeinamousemodel
AT quirozmercadohugo effectofhumanmilkasatreatmentfordryeyesyndromeinamousemodel
AT gregorydarreng effectofhumanmilkasatreatmentfordryeyesyndromeinamousemodel
AT petrashjmark effectofhumanmilkasatreatmentfordryeyesyndromeinamousemodel
AT mccourtemilya effectofhumanmilkasatreatmentfordryeyesyndromeinamousemodel